Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1234
Title: Initial experience with Allium™ stent in the management of bulbar urethral stricture.
Epworth Authors: Sigaly, Andrew
Merrett, Chris
Agarwal, Dinesh
Keywords: Urethral Stricture
Stent
Bulbar Urethral Stent
BUS
Allium™
Visual Internal Urethrotomy
VIU
Urethral Calculi
Bulbar Urethral Disease
Disease Management
UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Jul-2017
Publisher: AME Publishing Company
Citation: Transl Androl Urol. 2017 Jul;6(Suppl 2):S88-S91
Abstract: Abstract: We herein present our initial experience of a short series with the Allium™ Bulbar Urethral Stent (BUS) in the management of bulbar urethral disease. This Allium™ stent is a self-expandable metal stent which is intended for temporary placement. Our series is a retrospective analysis of 15 BUS placements in 13 patients conducted during 2014 to 2016. BUS was placed successfully after visual internal urethrotomy (VIU) in all patients. Stent insertion was successful in 8 patients (62%) with a mean follow up of 7.2 months (range, 2–12 months). Two of the failed patients stents were reinserted had repeat stenting with a successful outcome. The result of this short series suggests that BUS may have a limited role in the management of bulbar urethral stricture disease.
URI: http://hdl.handle.net/11434/1234
DOI: 10.21037/tau.2017.04.19
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522800/
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/28791227
ISSN: 2223-4691
Journal Title: Translational Andrology and Urology
Type: Journal Article
Affiliated Organisations: Footscray Hospital, Western Health, Footscray, Victoria, Australia
The Royal Melbourne Hospital, Melbourne Health, Parkville, Victoria, Australia
Type of Clinical Study or Trial: Review
Appears in Collections:UroRenal, Vascular

Files in This Item:
File Description SizeFormat 
Silagy et al 2017.pdf423.54 kBAdobe PDFView/Open


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.